Temporal Interference Stimulation Combined With Tai Chi for Mild Cognitive Impairment
Effects of Transcranial Temporal Interference Stimulation Combined With Tai Chi Training on Cognitive Function, Dual-Task Performance, and Neuroimaging Mechanisms in Individuals With Mild Cognitive Impairment
1 other identifier
interventional
120
1 country
1
Brief Summary
This study aims to evaluate whether individualized hippocampal transcranial temporal interference stimulation (tTIS) combined with Tai Chi training can improve cognitive function and dual-task performance in individuals with mild cognitive impairment. Participants will be randomly assigned to receive either active or sham individualized tTIS combined with Tai Chi training for 8 weeks. The study will also investigate changes in brain structure and function using neuroimaging and assess whether the intervention effects are maintained during follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2026
CompletedStudy Start
First participant enrolled
August 25, 2026
CompletedFirst Posted
Study publicly available on registry
September 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 25, 2027
September 2, 2026
August 1, 2026
11 months
August 24, 2026
August 27, 2026
Conditions
Outcome Measures
Primary Outcomes (30)
Change in Montreal Cognitive Assessment (MoCA) Score
Global cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA). The total score ranges from 0 to 30, with higher scores indicating better cognitive function. Changes from baseline will be evaluated after the intervention and at follow-up.
Baseline, Week 8, and Week 24
Change in Mini-Mental State Examination (MMSE) Score
Global cognitive function will also be assessed using the Mini-Mental State Examination (MMSE). The total score ranges from 0 to 30, with higher scores indicating better cognitive function. Changes from baseline will be evaluated after the intervention and at follow-up.
Baseline, Week 8, and Week 24
Change in Go/No-Go Task Accuracy
Inhibitory control will be assessed using accuracy on the Go/No-Go task. Accuracy will be expressed as the percentage of correct responses, with higher values indicating better performance.
Baseline, Week 8
Change in Go/No-Go Task Reaction Time
Inhibitory control will be assessed using reaction time for correct responses on the Go/No-Go task. Reaction time will be recorded in milliseconds (ms), with shorter reaction times indicating faster task performance.
Baseline and Week 8
Change in n-back Task Accuracy
Working memory performance will be assessed using accuracy on the n-back task. Accuracy will be expressed as the percentage of correct responses, with higher values indicating better performance.
Baseline, Week 8
Change in n-back Task Reaction Time
Working memory performance will be assessed using reaction time for correct responses on the n-back task. Reaction time will be recorded in milliseconds (ms), with shorter reaction times indicating faster task performance.
Baseline, Week 8
Change in Digit Span Forward Score
Attention and short-term memory will be assessed using the Digit Span Forward task. Performance will be recorded as the raw Digit Span Forward score, with higher scores indicating better performance.
Baseline and Week 8
Change in Digit Span Backward Score
Working memory will be assessed using the Digit Span Backward task. Performance will be recorded as the raw Digit Span Backward score, with higher scores indicating better performance.
Baseline and Week 8
Change in Auditory Verbal Learning Test Trial 1 Recall
Immediate verbal memory will be assessed using the number of words correctly recalled during Trial 1 (N1) of the Auditory Verbal Learning Test (AVLT). Higher numbers of correctly recalled words indicate better memory performance.
Baseline, Week 8, and Week 24
Change in Auditory Verbal Learning Test Trial 2 Recall
Verbal learning performance will be assessed using the number of words correctly recalled during Trial 2 (N2) of the Auditory Verbal Learning Test (AVLT). Higher numbers of correctly recalled words indicate better performance.
Baseline, Week 8, and Week 24
Change in Auditory Verbal Learning Test Trial 3 Recall
Verbal learning performance will be assessed using the number of words correctly recalled during Trial 3 (N3) of the Auditory Verbal Learning Test (AVLT). Higher numbers of correctly recalled words indicate better performance.
Baseline, Week 8, and Week 24
Change in Auditory Verbal Learning Test Trial 4 Recall
Verbal learning performance will be assessed using the number of words correctly recalled during Trial 4 (N4) of the Auditory Verbal Learning Test (AVLT). Higher numbers of correctly recalled words indicate better performance.
Baseline, Week 8, and Week 24
Change in Auditory Verbal Learning Test Trial 5 Recall
Verbal learning performance will be assessed using the number of words correctly recalled during Trial 5 (N5) of the Auditory Verbal Learning Test (AVLT). Higher numbers of correctly recalled words indicate better performance.
Baseline, Week 8, and Week 24
Change in Auditory Verbal Learning Test Recognition Correct Responses
Recognition memory will be assessed using the number of correct recognition responses on the Auditory Verbal Learning Test (AVLT). A higher number of correct recognition responses indicates better recognition memory.
Baseline, Week 8, and Week 24
Change in Auditory Verbal Learning Test Recognition Errors
Recognition memory errors will be assessed using the number of incorrect recognition responses on the Auditory Verbal Learning Test (AVLT). A lower number of recognition errors indicates better recognition memory performance.
Baseline, Week 8, and Week 24
Change in Face-Name Matching Task Accuracy
Associative episodic memory will be assessed using accuracy on the face-name matching task. Accuracy will be expressed as the percentage of correct responses, with higher values indicating better performance.
Baseline, Week 8, and Week 24
Change in Face-Name Matching Task Reaction Time
Associative episodic memory performance will be assessed using reaction time for correct responses on the face-name matching task. Reaction time will be recorded in milliseconds (ms), with shorter reaction times indicating faster task performance.
Baseline, Week 8, and Week 24
Change in Mnemonic Similarity Task Accuracy
Episodic memory and mnemonic discrimination will be assessed using accuracy on the Mnemonic Similarity Task (MST). Accuracy will be expressed as the percentage of correct responses, with higher values indicating better performance.
Baseline, Week 8, and Week 24
Change in Mnemonic Similarity Task Reaction Time
Performance on the Mnemonic Similarity Task (MST) will also be assessed using reaction time for correct responses. Reaction time will be recorded in milliseconds (ms), with shorter reaction times indicating faster task performance.
Baseline, Week 8, and Week 24
Change in Single-Task Timed Up and Go Completion Time
Mobility under single-task conditions will be assessed using the Timed Up and Go (TUG) test. Completion time will be recorded in seconds, with shorter completion times indicating better mobility performance.
Baseline and Week 8
Change in Dual-Task Timed Up and Go Completion Time
Cognitive-motor dual-task performance will be assessed using the Timed Up and Go (TUG) test performed concurrently with a cognitive task. Completion time will be recorded in seconds, with shorter completion times indicating better dual-task mobility performance.
Baseline and Week 8
Change in Timed Up and Go Dual-Task Cost
Dual-task cost for Timed Up and Go completion time will be calculated as \[(dual-task completion time - single-task completion time) / single-task completion time\] Ă— 100%. Higher positive values indicate greater deterioration in mobility performance under dual-task conditions.
Baseline and Week 8
Change in Single-Task Gait Speed
Gait speed under single-task walking conditions will be recorded in meters per second (m/s). Higher gait speed indicates faster walking performance.
Baseline and Week 8
Change in Dual-Task Gait Speed
Gait speed during cognitive-motor dual-task walking will be recorded in meters per second (m/s). Higher gait speed indicates faster walking performance during dual-tasking.
Baseline and Week 8
Change in Single-Task Gait Cadence
Gait cadence under single-task walking conditions will be recorded as steps per minute (steps/min). Higher values indicate a greater number of steps performed per minute.
Baseline and Week 8
Change in Dual-Task Gait Cadence
Gait cadence during cognitive-motor dual-task walking will be recorded as steps per minute (steps/min). Higher values indicate a greater number of steps performed per minute during dual-tasking.
Baseline and Week 8
Change in Single-Task Stride Length
Stride length under single-task walking conditions will be recorded in meters (m). Greater values indicate longer stride length.
Baseline and Week 8
Change in Dual-Task Stride Length
Stride length during cognitive-motor dual-task walking will be recorded in meters (m). Greater values indicate longer stride length during dual-tasking.
Baseline and Week 8
Change in Brain Structure and Function Assessed by Magnetic Resonance Imaging
Changes in brain structure and function will be assessed using multimodal magnetic resonance imaging (MRI). MRI-derived structural and functional measures will be used to characterize intervention-related brain changes.
Baseline, Week 8
Change in Brain Structure and Function Assessed by Magnetic Resonance Imaging
Changes in brain structure and function will be assessed using multimodal magnetic resonance imaging (MRI). MRI-derived structural and functional measures will be used to characterize intervention-related brain changes.
Baseline and Week 8
Secondary Outcomes (13)
Change in Hamilton Anxiety Rating Scale Score
Baseline, Week 8, and Week 24
Change in 17-Item Hamilton Depression Rating Scale Score
Baseline, Week 8, and Week 24
Change in 15-Item Geriatric Depression Scale Score
Baseline, Week 8, and Week 24
Change in Pittsburgh Sleep Quality Index Score
Baseline, Week 8, and Week 24
Change in Epworth Sleepiness Scale Score
Baseline, Week 8, and Week 24
- +8 more secondary outcomes
Study Arms (2)
Active tTIS Combined With Tai Chi
EXPERIMENTALParticipants will receive active individualized hippocampal transcranial temporal interference stimulation (tTIS) combined with Tai Chi training for 8 weeks, three sessions per week. Each tTIS session will last 20 minutes and each Tai Chi session approximately 60 minutes.
Placebo tTIS Combined With Tai Chi
EXPERIMENTALParticipants will receive sham individualized hippocampal transcranial temporal interference stimulation (tTIS) combined with the same Tai Chi training for 8 weeks, three sessions per week. Placebo (sham) stimulation will use the same electrode configuration and session duration as active stimulation but without effective stimulation during the main stimulation period.
Interventions
Placebo stimulation delivered using the same electrode placement and parameters as active stimulation. To mimic the sensory experience without effective neuromodulation, active current is delivered only during the 30-second ramp-up and ramp-down periods. During the 20-minute stimulation period, no current is delivered. Participants are unable to distinguish sham from active stimulation based on sensation. Sham stimulation will be administered three times per week for 8 weeks.
Participants will receive standardized Tai Chi training for approximately 60 minutes per session, three sessions per week for 8 weeks. The same Tai Chi training protocol will be provided to participants in both study arms.
Active tTIS delivered via surface electrodes targeting the hippocampus. Parameters: 2 mA baseline-to-peak intensity, 20-minute duration with 30-second ramp-up and ramp-down. The stimulation protocol is individualized based on each participant's T1-weighted structural MRI using finite element modeling to optimize electric field distribution to the hippocampal target. Stimulation will be administered three times per week for 8 weeks.
Eligibility Criteria
You may qualify if:
- Age 60-80 years
- Community-dwelling
- Montreal Cognitive Assessment (MoCA) score \< 26
- Clinical Dementia Rating (CDR) score = 0.5
- Activities of Daily Living (ADL) score \< 26 (largely intact daily function)
- Does not meet criteria for dementia diagnosis (based on DSM-5 or NIA-AA criteria)
- No contraindications for MRI examination (no metallic implants, no claustrophobia)
- Able to provide written informed consent
You may not qualify if:
- Neurological conditions that may cause cognitive decline (e.g., cerebrovascular disease, encephalitis, Parkinson's disease, Huntington's disease)
- Severe visual, auditory, or language impairments preventing completion of neuropsychological assessments
- Severe depression (Geriatric Depression Scale \> 10) or other major psychiatric disorders
- History of seizures or epilepsy
- Previous deep brain stimulation or electroconvulsive therapy within 6 months
- Alcohol or substance dependence
- Concurrent participation in another interventional clinical trial
- Contraindications for non-invasive brain stimulation: electronic or ferromagnetic implants, non-MRI compatible metal implants, history of seizures, pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanghai University of Sportlead
- Huashan Hospitalcollaborator
Study Sites (1)
Shanghai University of Sport
Shanghai, Shanghai Municipality, 200438, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 24, 2026
First Posted
September 2, 2026
Study Start
August 25, 2026
Primary Completion (Estimated)
July 25, 2027
Study Completion (Estimated)
July 25, 2027
Last Updated
September 2, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Beginning 6 months after publication of the main results.
- Access Criteria
- Data will be made available upon reasonable request to the corresponding author. Data will be shared with researchers who submit a methodologically sound research proposal and intend to use the data for non-commercial purposes. Applicants must sign a data access agreement.
De-identified individual participant data for primary and secondary outcome measures will be made available upon reasonable request to the corresponding author after publication of the main results.